Regeneration following spinal cord injury, from experimental models to humans: where are we?

Bibliography

• SEKHON LH, FEHLINGS MG: Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (2001) 26(24 Suppl.):S2-S12.
   PubMed Web of Science ®Google Scholar
• BASSO DM, BEATTIE MS, BRESNAHAN JC: Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. (1996) 139(2):244-256.
   PubMed Web of Science ®Google Scholar
• MA M, BASSO DM, WALTERS P, STOKES BT, JAKEMAN LB: Behavioral and histological outcomes following graded spinal cord contusion injury in the C57Bl/6 mouse. Exp. Neurol. (2001) 169(2):239-254.
   PubMedGoogle Scholar
• SROGA JM, JONES TB, KIGERL KA, MCGAUGHY VM, POPOVICH PG: Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J. Comp. Neurol. (2003) 462(2):223-240.
   PubMedGoogle Scholar
• SCHWAB ME, BARTHOLDI D: Degeneration and regeneration of axons in the lesioned spinal cord. Physiol. Rev. (1996) 76(2):319-70.
   PubMed Web of Science ®Google Scholar
• NORENBERG MD, SMITH J, MARCILLO A: The pathology of human spinal cord injury: defining the problems. J. Neurotrauma (2004) 21(4):429-440.
   PubMed Web of Science ®Google Scholar
• EIDELBERG E, STRAEHLEY D, ERSPAMER R, WATKINS CJ: Relationship between residual hindlimb-assisted locomotion and surviving axons after incomplete spinal cord injuries. Exp. Neurol. (1977) 56(2):312-322.
   PubMed Web of Science ®Google Scholar
• KWON BK, TETZLAFF W, GRAUER JN, BEINER J, VACARO AR: Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J. (2004) 4(4):451-464.
   PubMedGoogle Scholar
• YAKOVLEV AG, FADEN AI: Caspase-dependent apoptotic pathways in CNS injury. Mol. Neurobiol. (2001) 24(1-3):131-144.
   PubMed Web of Science ®Google Scholar
• PARK E, VELUMIAN AA, FEHLINGS MG: The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J. Neurotrauma (2004) 21(6):754-774.
   PubMed Web of Science ®Google Scholar
• SAVILLE LR, POSPISIL CH, MAWHINNEY LA et al.: A monoclonal antibody to CD11d reduces the inflammatory infiltrate into the injured spinal cord: a potential neuroprotective treatment. J. Neuroimmunol. (2004) 156(1-2):42-57.
   PubMedGoogle Scholar
• BARTHOLDI D, SCHWAB ME: Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur. J. Neurosci. (1997) 9(7):1422-1438.
   PubMed Web of Science ®Google Scholar
• POPOVICH PG, VAN ROOIJEN N, HICKEY WF, PREIDIS G, MCGAUGHY V: Hematogenous macrophages express CD8 and distribute to regions of lesion cavitation after spinal cord injury. Exp. Neurol. (2003) 182(2):275-287.
   PubMedGoogle Scholar
• BETHEA JR, NAGASHIMA H, ACOSTA MC et al.: Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma (1999) 16(10):851-863.
   PubMed Web of Science ®Google Scholar
• BETHEA JR, DIETRICH WD: Targeting the host inflammatory response in traumatic spinal cord injury. Curr. Opin. Neurol. (2002) 15(3):355-360.
   PubMed Web of Science ®Google Scholar
• BRAMBILLA R, BRACCHI-RICARD V, HU WH et al.: Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. (2005) 202(1):145-156.
   PubMed Web of Science ®Google Scholar
• BAO F, DEKABAN GA, WEAVER L: Anti-CD11d antibody treatment reduces free radical formation and cell death in the injured spinal cord of rats. J. Neurochem. (2005) 94(5):1361-1373.
   PubMedGoogle Scholar
• RIBOTTA MG, MENET V, PRIVAT A: Glial scar and axonal regeneration in the CNS: lessons from GFAP and vimentin transgenic mice. Acta Neurochir. Suppl. (2004) 89:87-92.
   PubMedGoogle Scholar
• SILVER J, MILLER JH: Regeneration beyond the glial scar. Nat. Rev. Neurosci. (2004) 5(2):146-56.
   PubMed Web of Science ®Google Scholar
• DREYFUS CF, DAI X, LERCHER LD, RACEY BR, FRIEDMAN WJ, BLACK IB: Expression of neurotrophins in the adult spinal cord in vivo. J. Neurosci. Res. (1999) 56(1):1-7.
   PubMedGoogle Scholar
• HSU JY, STEIN SA, XU XM: Temporal and spatial distribution of growth-associated molecules and astroglial cells in the rat corticospinal tract during development. J. Neurosci. Res. (2005) 80(3):330-340.
   PubMedGoogle Scholar
• DOUCET G, PETIT A: Seeking axon guidance molecules in the adult rat CNS. Prog. Brain Res. (2002) 137:453-465.
   PubMedGoogle Scholar
• DUMONT RJ, OKONKWO DO, VERMA S et al.: Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin. Neuropharmacol. (2001) 24(5):254-264.
   PubMed Web of Science ®Google Scholar
• YAKOVLEV AG, FADEN AI: Molecular biology of CNS injury. J. Neurotrauma (1995) 12(5):767-777.
   PubMedGoogle Scholar
• FOURNIER AE, STRITTMATTER SM: Regenerating nerves follow the road more traveled. Nat. Neurosci. (2002) 5(9):821-822.
   PubMedGoogle Scholar
• MAKWANA M, RAIVICH G: Molecular mechanisms in successful peripheral regeneration. FEBS J. (2005) 272(11):2628-2638.
   PubMed Web of Science ®Google Scholar
• HE Z, KOPRIVICA V: The Nogo signaling pathway for regeneration block. Ann. Rev. Neurosci. (2004) 27:341-368.
   Google Scholar
• CHEN MS, HUBER AB, VAN DER HAAR ME et al.: Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature (2000) 403(6768):434-439.
   PubMed Web of Science ®Google Scholar
• GRANDPRE T, NAKAMURA F, VARTANIAN T, STRITTMATTER SM: Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature (2000) 403(6768):439-444.
   PubMed Web of Science ®Google Scholar
• DEBELLARD ME, TANG S, MUKHOPADHYAY G, SHEN YJ, FILBIN MT: Myelin-associated glycoprotein inhibits axonal regeneration from a variety of neurons via interaction with a sialoglycoprotein. Mol. Cell. Neurosci. (1996) 7(2):89-101.
   PubMed Web of Science ®Google Scholar
• MUKHOPADHYAY G, DOHERTY P, WALSH FS, CROCKER PR, FILBIN MT: A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron (1994) 13(3):757-767.
   PubMed Web of Science ®Google Scholar
• DOMENICONI M, FILBIN MT: Overcoming inhibitors in myelin to promote axonal regeneration. J. Neurol. Sci (2005) 233(1-2):43-47.
   PubMed Web of Science ®Google Scholar
• YIU G, HE Z: Signaling mechanisms of the myelin inhibitors of axon regeneration. Curr. Opin. Neurobiol. (2003) 13(5):545-551.
   PubMed Web of Science ®Google Scholar
• MI S, LEE X, SHAO Z et al.: LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat. Neurosci. (2004) 7(3):221-228.
   PubMed Web of Science ®Google Scholar
• WANG KC, KIM JA, SIVASANKARAN R, SEGAL R, HE Z: P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature (2002) 420(6911):74-78.
   PubMed Web of Science ®Google Scholar
• WANG KC, KOPRIVICA V, KIM JA et al.: Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature (2002) 417(6892):941-944.
   PubMed Web of Science ®Google Scholar
• WONG ST, HENLEY JR, KANNING KC, HUANG KH, BOTHWELL M, POO MM: A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat. Neurosci. (2002) 5(12):1302-1308.
   PubMed Web of Science ®Google Scholar
• NIEDEROST B, OERTLE T, FRITSCHE J, MCKINNEY RA, BANDTLOW CE: Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J. Neurosci. (2002) 22(23):10368-10376.
   PubMed Web of Science ®Google Scholar
• ALABED YZ, GRADOS-MUNRO E, FERRARO GB, HSIEH SH, FOURNIER AE: Neuronal responses to myelin are mediated by rho kinase. J. Neurochem. (2006) 96(6):1616-1625.
   PubMedGoogle Scholar
• OERTLE T, VAN DER HAAR ME, BANDTLOW CE et al.: Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J. Neurosci. (2003) 23(13):5393-5406.
   PubMed Web of Science ®Google Scholar
• HUBER AB, SCHWAB ME: Nogo-A, a potent inhibitor of neurite outgrowth and regeneration. Biol. Chem. (2000) 381(5-6):407-419.
   PubMedGoogle Scholar
• POT C, SIMONEN M, WEINMANN O et al.: Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury. J. Cell Biol. (2002) 159(1):29-35.
   PubMed Web of Science ®Google Scholar
• SIMONEN M, PEDERSEN V, WEINMANN O et al.: Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron (2003) 38(2):201-211.
   PubMed Web of Science ®Google Scholar
• ZHENG B, HO C, LI S, KEIRSTEAD H, STEWARD O, TESSIER-LAVIGNE M: Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron (2003) 38(2):213-224.
   PubMed Web of Science ®Google Scholar
• KIM JE, LI S, GRANDPRE T, QIU D, STRITTMATTER SM: Axon regeneration in young adult mice lacking Nogo-A/B. Neuron (2003) 38(2):187-199.
   PubMed Web of Science ®Google Scholar
• ZHENG B, ATWAL J, HO C et al.: Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc. Natl. Acad. Sci. USA (2005) 102(4):1205-1210.
   PubMed Web of Science ®Google Scholar
• SCHAFER M, FRUTTIGER M, MONTAG D, SCHACHNER M, MARTINI R: Disruption of the gene for the myelin-associated glycoprotein improves axonal regrowth along myelin in C57BL/Wlds mice. Neuron (1996) 16(6):1107-1113.
   PubMed Web of Science ®Google Scholar
• BARTSCH U, BANDTLOW CE, SCHNELL L et al.: Lack of evidence that myelin-associated glycoprotein is a major inhibitor of axonal regeneration in the CNS. Neuron (1995) 15(6):1375-1381.
   PubMed Web of Science ®Google Scholar
• SHEN YJ, DEBELLARD ME, SALZER JL, RODER J, FILBIN MT: Myelin-associated glycoprotein in myelin and expressed by Schwann cells inhibits axonal regeneration and branching. Mol. Cell. Neurosci. (1998) 12(1-2):79-91.
   PubMed Web of Science ®Google Scholar
• BARTON WA, LIU BP, TZVETKOVA D et al.: Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins. EMBO J. (2003) 22(13):3291-3302.
   PubMed Web of Science ®Google Scholar
• KOTTIS V, THIBAULT P, MIKOL D et al.: Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J. Neurochem. (2002) 82(6):1566-1569.
   PubMed Web of Science ®Google Scholar
• BENSON MD, ROMERO MI, LUSH ME, LU QR, HENKEMEYER M, PARADA LF: Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth. Proc. Natl. Acad. Sci. USA (2005) 102(30):10694-10699.
   PubMed Web of Science ®Google Scholar
• YAMASHITA T, TUCKER KL, BARDE YA: Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth. Neuron (1999) 24(3):585-593.
   PubMed Web of Science ®Google Scholar
• YAMASHITA T, TOHYAMA M: The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat. Neurosci. (2003) 6(5):461-467.
   PubMed Web of Science ®Google Scholar
• DUBREUIL CI, WINTON MJ, MCKERRACHER L: Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J. Cell Biol. (2003) 162(2):233-243.
   PubMed Web of Science ®Google Scholar
• SHAO Z, BROWNING JL, LEE X et al.: TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron (2005) 45(3):353-359.
   PubMed Web of Science ®Google Scholar
• PARK JB, YIU G, KANEKO S et al.: A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron (2005) 45(3):345-351.
   PubMed Web of Science ®Google Scholar
• BERTRAND J, WINTON MJ, RODRIGUEZ-HERNANDEZ N, CAMPENOT RB, MCKERRACHER L: Application of Rho antagonist to neuronal cell bodies promotes neurite growth in compartmented cultures and regeneration of retinal ganglion cell axons in the optic nerve of adult rats. J. Neurosci. (2005) 25(5):1113-1121.
   PubMed Web of Science ®Google Scholar
• LEHMANN M, FOURNIER A, SELLES-NAVARRO I et al.: Inactivation of Rho signaling pathway promotes CNS axon regeneration. J. Neurosci. (1999) 19(17):7537-7547.
   PubMed Web of Science ®Google Scholar
• FOURNIER AE, TAKIZAWA BT, STRITTMATTER SM: Rho kinase inhibition enhances axonal regeneration in the injured CNS. J. Neurosci. (2003) 23(4):1416-1423.
   PubMed Web of Science ®Google Scholar
• CHAN CC, KHODARAHMI K, LIU J et al.: Dose-dependent beneficial and detrimental effects of ROCK inhibitor Y27632 on axonal sprouting and functional recovery after rat spinal cord injury. Exp. Neurol. (2005) 196(2):352-364.
   PubMedGoogle Scholar
• MORGENSTERN DA, ASHER RA, FAWCETT JW: Chondroitin sulphate proteoglycans in the CNS injury response. Prog. Brain Res. (2002) 137:313-332.
   PubMed Web of Science ®Google Scholar
• JONES LL, MARGOLIS RU, TUSZYNSKI MH: The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp. Neurol. (2003) 182(2):399-411.
   PubMed Web of Science ®Google Scholar
• KRAUTSTRUNK M, SCHOLTES F, MARTIN D et al.: Increased expression of the putative axon growth-repulsive extracellular matrix molecule, keratan sulphate proteoglycan, following traumatic injury of the adult rat spinal cord. Acta Neuropathol. (Berl) (2002) 104(6):592-600.
   PubMedGoogle Scholar
• LEMONS ML, HOWLAND DR, ANDERSON DK: Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation. Exp. Neurol. (1999) 160(1):51-65.
   PubMed Web of Science ®Google Scholar
• JONES LL, SAJED D, TUSZYNSKI MH: Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition. J. Neurosci. (2003) 23(28):9276-9288.
   PubMed Web of Science ®Google Scholar
• CAMAND E, MOREL MP, FAISSNER A, SOTELO C, DUSART I: Long-term changes in the molecular composition of the glial scar and progressive increase of serotoninergic fibre sprouting after hemisection of the mouse spinal cord. Eur. J. Neurosci. (2004) 20(5):1161-1176.
   PubMed Web of Science ®Google Scholar
• MENET V, PRIETO M, PRAVAT A: Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes. Proc. Natl. Acad. Sci. USA (2003) 100(15):8999-9004.
   PubMedGoogle Scholar
• KOPRIVICA V, CHO K-S, PARK JB et al.: EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans. Science (2005) 310(5745):106-110.
   PubMed Web of Science ®Google Scholar
• RAIVICH G, BOHATSCHEK M, DA COSTA C et al.: The AP-1 transcription factor c-Jun is required for efficient axonal regeneration. Neuron (2004) 43(1):57-67.
   PubMed Web of Science ®Google Scholar
• ZHOU FQ, WALZER MA, SNIDER WD: Turning on the machine: genetic control of axon regeneration by c-Jun. Neuron (2004) 43(1):1-2.
   PubMed Web of Science ®Google Scholar
• KNOOPS B, OCTAVE JN: Alpha 1-tubulin mRNA level is increased during neurite outgrowth of NG 108-15 cells but not during neurite outgrowth inhibition by CNS myelin. Neuroreport (1997) 8(3):795-798.
   PubMed Web of Science ®Google Scholar
• GLOSTER A, WU W, SPEELMAN A et al.: The T alpha 1 alpha-tubulin promoter specifies gene expression as a function of neuronal growth and regeneration in transgenic mice. J. Neurosci. (1994) 14(12):7319-7330.
   PubMed Web of Science ®Google Scholar
• DI GIOVANNI S, DE BIASE A, YAKOVLEV A et al.: In vivo and in vitro characterization of novel neuronal plasticity factors identified following spinal cord injury. J. Biol. Chem. (2005) 280(3):2084-2091.
   PubMed Web of Science ®Google Scholar
• TUCKER RP: The roles of microtubule-associated proteins in brain morphogenesis: a review. Brain Res. Brain Res. Rev. (1990) 15(2):101-120.
   PubMedGoogle Scholar
• LAUX T, FUKAMI K, THELEN M, GOLUB T, FREY D, CARONI P: GAP43, MARCKS, and CAP23 modulate PI(4,5)P(2) at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism. J. Cell Biol. (2000) 149(7):1455-1472.
   PubMed Web of Science ®Google Scholar
• FREY D, LAUX T, XU L, SCHNEIDER C, CARONI P: Shared and unique roles of CAP23 and GAP43 in actin regulation, neurite outgrowth, and anatomical plasticity. J. Cell Biol. (2000) 149(7):1443-1454.
   PubMed Web of Science ®Google Scholar
• CARONI P, GRANDES P: Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors. J. Cell Biol. (1990) 110(4):1307-1317.
   PubMed Web of Science ®Google Scholar
• AIGNER L, ARBER S, KAPFHAMMER JP et al.: Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell (1995) 83(2):269-278.
   PubMed Web of Science ®Google Scholar
• AIGNER L, CARONI P: Depletion of 43-kD growth-associated protein in primary sensory neurons leads to diminished formation and spreading of growth cones. J. Cell Biol. (1993) 123(2):417-29.
   PubMed Web of Science ®Google Scholar
• JUNG M, PETRAUSCH B, STUERMER CA: Axon-regenerating retinal ganglion cells in adult rats synthesize the cell adhesion molecule L1 but not TAG-1 or SC-1. Mol. Cell. Neurosci. (1997) 9(2):116-131.
   PubMed Web of Science ®Google Scholar
• KLOCKER N, JUNG M, STUERMER CAO, BAHR M: BDNF increases the number of axotomized rat retinal ganglion cells expressing GAP-43, L1, and TAG-1 mRNA-a supportive role for nitric oxide? Neurobiol. Dis. (2001) 8(1):103-113.
   PubMed Web of Science ®Google Scholar
• DI GIOVANNI S, FADEN AI, YAKOVLEV A et al.: Neuronal plasticity after spinal cord injury: identification of a gene cluster driving neurite outgrowth. FASEB J. (2005) 19(1):153-154.
   PubMedGoogle Scholar
• NAEVE GS, RAMAKRIHNAN M, KRAMER R, HEVRONI D, CITRI Y, THEILL LE: Neuritin: a gene induced by neural activity and neurotrophins that promotes neuritogenesis. Proc. Natl. Acad. Sci. USA (1997) 94(6):2648-2653.
   PubMed Web of Science ®Google Scholar
• KIMURA K, MIZOGUCHI A, IDE C: Regulation of growth cone extension by SNARE proteins. J. Histochem. Cytochem. (2003) 51(4):429-433.
   PubMed Web of Science ®Google Scholar
• CARONI P: New EMBO members’ review: actin cytoskeleton regulation through modulation of PI(4,5)P(2) rafts. EMBO J. (2001) 20(16):4332-4336.
   PubMed Web of Science ®Google Scholar
• BOMZE HM, BULSARA KR, ISKANDAR BJ, CARONI P, SKENE JH et al.: Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons. Nat. Neurosci. (2001) 4(1):38-43.
   PubMed Web of Science ®Google Scholar
• BENOWITZ LI, GOLDBERG DE, IRWIN N: Inosine stimulates axon growth in vitro and in the adult CNS. Prog. Brain Res. (2002) 137:389-399.
   PubMedGoogle Scholar
• TESSLER A: Neurotrophic effects on dorsal root regeneration into the spinal cord. Prog. Brain Res. (2004) 143:147-154.
   PubMedGoogle Scholar
• BREGMAN BS, COUMANS JV, DAI HN et al.: Transplants and neurotrophic factors increase regeneration and recovery of function after spinal cord injury. Prog. Brain Res. (2002) 137:257-273.
   PubMed Web of Science ®Google Scholar
• PLUNET W, KWON BK, TETZLAFF W: Promoting axonal regeneration in the central nervous system by enhancing the cell body response to axotomy. J. Neurosci. Res. (2002) 68(1):1-6.
   PubMed Web of Science ®Google Scholar
• WIDENFALK J, LUNDSTROMER K, JUBRAN M, BRENE S, OLSON L: Neurotrophic factors and receptors in the immature and adult spinal cord after mechanical injury or kainic acid. J. Neurosci. (2001) 21(10):3457-3475.
   PubMed Web of Science ®Google Scholar
• FERNANDEZ E, PALLINI R, MERCANTI D: Effects of topically administered nerve growth factor on axonal regeneration in peripheral nerve autografts implanted in the spinal cord of rats. Neurosurgery (1990) 26(1):37-42.
   PubMed Web of Science ®Google Scholar
• COUMANS JV, LIN TTS, DAI HN et al.: Axonal regeneration and functional recovery after complete spinal cord transection in rats by delayed treatment with transplants and neurotrophins. J. Neurosci. (2001) 21(23):9334-9344.
   PubMed Web of Science ®Google Scholar
• LIU Y, HIMES BT, MURRAY M, TESSLAR A, FISCHER I: Grafts of BDNF-producing fibroblasts rescue axotomized rubrospinal neurons and prevent their atrophy. Exp. Neurol. (2002) 178(2):150-164.
   PubMed Web of Science ®Google Scholar
• LIU Y, KIM D, HIMES BT et al.: Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J. Neurosci. (1999) 19(11):4370-4387.
   PubMed Web of Science ®Google Scholar
• KIM D, SCHALLERT T, LIU Y et al.: Transplantation of genetically modified fibroblasts expressing BDNF in adult rats with a subtotal hemisection improves specific motor and sensory functions. Neurorehabil. Neural. Repair (2001) 15(2):141-150.
   PubMed Web of Science ®Google Scholar
• GRILL R, MURAI K, BLESCH A, GAGE FH, TUSZYNSKI MH: Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J. Neurosci. (1997) 17(14):5560-5572.
   PubMed Web of Science ®Google Scholar
• APFEL SC: Is the therapeutic application of neurotrophic factors dead? Ann. Neurol. (2002) 51(1):8-11.
   Google Scholar
• CONTI M, RICHTER W, MEHATS C, LIVERA G, PARK JY, JIN C: Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J. Biol. Chem. (2003) 278(8):5493-5496.
   PubMed Web of Science ®Google Scholar
• SUNAHARA RK, TAUSSIG R: Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. Mol. Interv. (2002) 2(3):168-184.
   PubMedGoogle Scholar
• SHAYWITZ AJ, GREENBERG ME: CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Ann. Rev. Biochem. (1999) 68:821-861.
   PubMed Web of Science ®Google Scholar
• CONKRIGHT MD, MONTMINY M: CREB: the unindicted cancer co-conspirator. Trends Cell Biol. (2005) 15(9):457-459.
   PubMed Web of Science ®Google Scholar
• LIU HH, BRADY ST: cAMP, tubulin, axonal transport, and regeneration. Exp. Neurol. (2004) 189(2):199-203.
   PubMedGoogle Scholar
• CAI D, SHEN Y, DE BELLARD M, TANG S, FILBIN MT: Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism. Neuron (1999) 22(1):89-101.
   PubMed Web of Science ®Google Scholar
• SONG H, MING G, HE Z et al.: Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides. Science (1998) 281(5382):1515-1518.
   PubMed Web of Science ®Google Scholar
• MING GL, SONG HJ, BERNINGER B, HOLT CE, TESSIER-LAVIGNE M, POO MM: cAMP-dependent growth cone guidance by netrin-1. Neuron (1997) 19(6):1225-1235.
   PubMed Web of Science ®Google Scholar
• QIU J, CAI D, DAI H et al.: Spinal axon regeneration induced by elevation of cyclic AMP. Neuron (2002) 34(6):895-903.
   PubMed Web of Science ®Google Scholar
• NEUMANN S, BRADKE F, TESSIER-LAVIGNE M, BASBAUM AI: Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation. Neuron (2002) 34(6):885-893.
   PubMed Web of Science ®Google Scholar
• CAI D, QIU J, CAO Z, MCATEE M, BREGMAN BS, FILBIN MT: Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate. J. Neurosci. (2001) 21(13):4731-4739.
   PubMed Web of Science ®Google Scholar
• NIKULINA E, TIDWELL JL, DAI HN, BREGMAN BS, FILBIN MT: The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proc. Natl Acad. Sci. USA (2004) 101(23):8786-8790.
   PubMed Web of Science ®Google Scholar
• WONG LF, YIP PK, BATTAGLIA A et al.: Retinoic acid receptor beta2 promotes functional regeneration of sensory axons in the spinal cord. Nat. Neurosci. (2006) 9(2):243-250.
   PubMed Web of Science ®Google Scholar
• HIEBERT GW, KHODARAHMI K, MCGRAW J, STEEVES JD, TETZLAFF W: Brain-derived neurotrophic factor applied to the motor cortex promotes sprouting of corticospinal fibers but not regeneration into a peripheral nerve transplant. J. Neurosci. Res. (2002) 69(2):160-168.
   PubMed Web of Science ®Google Scholar
• RICHARDSON PM, MCGUINNESS UM, AGUAYO AJ: Peripheral nerve autografts to the rat spinal cord: studies with axonal tracing methods. Brain Res. (1982) 237(1):147-162.
   PubMed Web of Science ®Google Scholar
• TETZLAFF W, KOBAYASHI NR, GIEHL KM, TSUI BJ, CASSAR SL, BEDARD AM: Response of rubrospinal and corticospinal neurons to injury and neurotrophins. Prog. Brain Res. (1994) 103:271-286.
   PubMed Web of Science ®Google Scholar
• CHENG H, ALMSTROM S, GIMENEZ-LLORT L et al.: Gait analysis of adult paraplegic rats after spinal cord repair. Exp. Neurol. (1997) 148(2):544-557.
   PubMed Web of Science ®Google Scholar
• CHENG H, CAO Y, OLSON L: Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function. Science (1996) 273(5274):510-513.
   PubMed Web of Science ®Google Scholar
• XU XM, CHEN A, GUENARD V, KLEITMAN N, BUNGE MB: Bridging Schwann cell transplants promote axonal regeneration from both the rostral and caudal stumps of transected adult rat spinal cord. J. Neurocytol. (1997) 26(1):1-16.
   PubMedGoogle Scholar
• TAKAMI T, OUDEGA M, BATES ML, WOOD PM, KLEITMAN N, BUNGE MB: Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. J. Neurosci. (2002) 22(15):6670-6681.
   PubMed Web of Science ®Google Scholar
• BAMBER NI, LI H, LU X, OUDEGA M, AEBISCHER P, XU XM: Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels. Eur. J. Neurosci. (2001) 13(2):257-268.
   PubMed Web of Science ®Google Scholar
• GIRARD C, BEMELMANS AP, DUFOUR N et al.: Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord. J. Neurosci. (2005) 25(35):7924-7933.
   PubMed Web of Science ®Google Scholar
• GUEST JD, RAO A, OLSON L, BUNGE MB, BUNGE RP: The ability of human Schwann cell grafts to promote regeneration in the transected nude rat spinal cord. Exp. Neurol. (1997) 148(2):502-522.
   PubMed Web of Science ®Google Scholar
• MORENO-FLORES MT, DIAZ-NIDO J, WANDOSELL F, AVILA J: Olfactory ensheathing glia: drivers of axonal regeneration in the central nervous system? J. Biomed. Biotechnol. (2002) 2(1):37-43.
   PubMedGoogle Scholar
• RAMON-CUETO A, CORDERO MI, SANTOS-BENITO FF, AVILA J: Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron (2000) 25(2):425-435.
   PubMed Web of Science ®Google Scholar
• LU J, FERON F, HO SM, MACKAY-SIM A, WAITE PM: Transplantation of nasal olfactory tissue promotes partial recovery in paraplegic adult rats. Brain Res. (2001) 889(1-2):344-357.
   PubMed Web of Science ®Google Scholar
• LU J, FERON F, MACKAY-SIM A, WAITE PM: Olfactory ensheathing cells promote locomotor recovery after delayed transplantation into transected spinal cord. Brain (2002) 125(Pt 1):14-21.
   PubMed Web of Science ®Google Scholar
• RUITENBERG MJ, LEVISON DB, LEE SV, VERHAAGEN J, HARVEY AR, PLANT GW: NT-3 expression from engineered olfactory ensheathing glia promotes spinal sparing and regeneration. Brain (2005) 128(Pt 4):839-853.
   PubMed Web of Science ®Google Scholar
• CAO L, LIU L, CHEN Z-Y et al.: Olfactory ensheathing cells genetically modified to secrete GDNF to promote spinal cord repair. Brain (2004) 127(Pt 3):535-549.
   PubMed Web of Science ®Google Scholar
• LOPEZ-VALES R, FORES J, VERDU E, NAVARRO X: Acute and delayed transplantation of olfactory ensheathing cells promote partial recovery after complete transection of the spinal cord. Neurobiol. Dis. (2006) 21(1):57-68.
   PubMedGoogle Scholar
• LI Y, FIELD PM, RAISMAN G: Regeneration of adult rat corticospinal axons induced by transplanted olfactory ensheathing cells. J. Neurosci. (1998) 18(24):10514-10524.
   PubMed Web of Science ®Google Scholar
• KEYVAN-FOULADI N, RAISMAN G, LI Y: Functional repair of the corticospinal tract by delayed transplantation of olfactory ensheathing cells in adult rats. J. Neurosci. (2003) 23(28):9428-9434.
   PubMed Web of Science ®Google Scholar
• HUANG H, CHEN L, WANG H et al.: Influence of patients’ age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury. Chin. Med. J. (Engl) (2003) 116(10):1488-1491.
   PubMed Web of Science ®Google Scholar
• RAPALINO O, LAZAROV-SPIEGLER O, AGRANOV E et al.: Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat. Med. (1998) 4(7):814-821.
   PubMed Web of Science ®Google Scholar
• POPOVICH PG, GUAN Z, MCGAUGHY V, FISHER L, HICKEY WF, BASSO DM: The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J. Neuropathol. Exp. Neurol. (2002) 61(7):623-633.
   PubMed Web of Science ®Google Scholar
• CERNAK I, STOICA B, BYRNES KR, DI GIOVANNI S, FADEN AI et al.: Role of the cell cycle in the pathobiology of central nervous system trauma. Cell Cycle (2005) 4(9):1286-1293.
   PubMed Web of Science ®Google Scholar
• DI GIOVANNI S, MOVSESYAN V, AHMED F et al.: Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc. Natl. Acad. Sci. USA (2005) 102(23):8333-8338.
   PubMed Web of Science ®Google Scholar
• POPOVICH PG, GUAN Z, WEI P, HUITINGA I, VAN ROOIJEN N, STOKES BT: Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. (1999) 158(2):351-365.
   PubMed Web of Science ®Google Scholar
• KNOLLER N, ANERBACH G, FULGA V et al.: Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: Phase I study results. J. Neurosurg. Spine (2005) 3(3):173-181.
   PubMed Web of Science ®Google Scholar
• TESSLER A, FISCHER I, GISZTER S et al.: Embryonic spinal cord transplants enhance locomotor performance in spinalized newborn rats. Adv. Neurol. (1997) 72:291-303.
   PubMedGoogle Scholar
• BREGMAN BS, KUNKEL-BAGDEN E, REIER PJ, DAI HN, MCATEE M, GAO D: Recovery of function after spinal cord injury: mechanisms underlying transplant-mediated recovery of function differ after spinal cord injury in newborn and adult rats. Exp. Neurol. (1993) 123(1):3-16.
   PubMed Web of Science ®Google Scholar
• WEISSMAN IL, ANDERSON DJ, GAGE F: Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Ann. Rev. Cell Dev. Biol. (2001) 17:387-403.
   PubMed Web of Science ®Google Scholar
• MAYER-PROSCHEL M, KALYANI AJ, MUJTABA T, RAO MS: Isolation of lineage-restricted neuronal precursors from multipotent neuroepithelial stem cells. Neuron (1997) 19(4):773-785.
   PubMed Web of Science ®Google Scholar
• KALYANI A, HOBSON K, RAO MS: Neuroepithelial stem cells from the embryonic spinal cord: isolation, characterization, and clonal analysis. Dev. Biol. (1997) 186(2):202-223.
   PubMed Web of Science ®Google Scholar
• MUJTABA T, PIPER DR, KALYANI A, GROVES AK, LUCERO MT, RAO MS: Lineage-restricted neural precursors can be isolated from both the mouse neural tube and cultured ES cells. Dev. Biol. (1999) 214(1):113-127.
   PubMed Web of Science ®Google Scholar
• EMSLEY JG, MITCHELL BD, MAGAVI SS, ARLOTTA PP, MACKLIS JD: The repair of complex neuronal circuitry by transplanted and endogenous precursors. NeuroRx (2004) 1(4):452-471.
   PubMedGoogle Scholar
• MITCHELL BD, EMSLEY JG, MAGAVI SS, ARLOTTA P, MACKLIS JD et al.: Constitutive and induced neurogenesis in the adult mammalian brain: manipulation of endogenous precursors toward CNS repair. Dev. Neurosci. (2004) 26(2-4):101-117.
   PubMed Web of Science ®Google Scholar
• EMSLEY JG, MITCHELL BD, KEMPERMANN G, MACKLIS JD: Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells. Prog. Neurobiol. (2005) 75(5):321-341.
   PubMed Web of Science ®Google Scholar
• GOLDMAN S: Stem and progenitor cell-based therapy of the human central nervous system. Nat. Biotechnol. (2005) 23(7):862-871.
   PubMed Web of Science ®Google Scholar
• HOFSTETTER CP, HOLMSTROM NA, LILJA JA et al.: Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat. Neurosci. (2005) 8(3):346-353.
   PubMed Web of Science ®Google Scholar
• LIU Y, HIMES BT, SOLOWSKA J et al.: Intraspinal delivery of neurotrophin-3 using neural stem cells genetically modified by recombinant retrovirus. Exp. Neurol. (1999) 158(1):9-26.
   PubMed Web of Science ®Google Scholar
• OGAWA Y, SAWAMOTO K, MIYATA T et al.: Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J. Neurosci. Res. (2002) 69(6):925-933.
   PubMed Web of Science ®Google Scholar
• OUREDNIK J, OUREDNIK V, LYNCH WP, SCHACHNER M SNYDER EY: Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat. Biotechnol. (2002) 20(11):1103-1110.
   PubMed Web of Science ®Google Scholar
• MCDONALD JW, LIU XZ, QU Y et al.: Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat. Med. (1999) 5(12):1410-1412.
   PubMed Web of Science ®Google Scholar
• LIU S, QU Y, STEWART TJ et al.: Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc. Natl. Acad. Sci. USA (2000) 97(11):6126-6131.
   PubMed Web of Science ®Google Scholar
• KEIRSTEAD HS, NISTOR G, BERNAL G et al.: Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. (2005) 25(19):4694-4705.
   PubMed Web of Science ®Google Scholar
• YAN J, WELSH AM, BORA SH, SNYDER EY, KOLIATSOV VE: Differentiation and tropic/trophic effects of exogenous neural precursors in the adult spinal cord. J. Comp. Neurol. (2004) 480(1):101-114.
   PubMed Web of Science ®Google Scholar
• CUMMINGS BJ, UCHIDA N, TAMAKI SJ et al.: Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc. Natl. Acad. Sci. USA (2005) 102(39):14069-14074.
   PubMed Web of Science ®Google Scholar
• IWANAMI A, KANEKO S, NAKAMURA M et al.: Transplantation of human neural stem cells for spinal cord injury in primates. J. Neurosci. Res. (2005) 80(2):182-190.
   PubMed Web of Science ®Google Scholar
• LEE VM, HARTLEY RS, TROJANOWSKI JQ: Neurobiology of human neurons (NT2N) grafted into mouse spinal cord: implications for improving therapy of spinal cord injury. Prog. Brain Res. (2000) 128:299-307.
   PubMedGoogle Scholar
• IKEDA R, KUROKAWA MS, CHIBA S et al.: Transplantation of neural cells derived from retinoic acid-treated cynomolgus monkey embryonic stem cells successfully improved motor function of hemiplegic mice with experimental brain injury. Neurobiol. Dis. (2005) 20(1):38-48.
   PubMedGoogle Scholar
• NEWMAN MB, MISIUTA I, WILLING AE et al.: Tumorigenicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells. Stem Cells Dev. (2005) 14(1):29-43.
   PubMed Web of Science ®Google Scholar
• HARTLEY RS, MARGULIS M, FISHMAN PS, LEE VM, TANG CM: Functional synapses are formed between human NTera2 (NT2N, hNT) neurons grown on astrocytes. J. Comp. Neurol. (1999) 407(1):1-10.
   PubMed Web of Science ®Google Scholar
• PEARSE DD, PEREIRA FC, MARCILLO AE et al.: cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat. Med. (2004) 10(6):610-616.
   PubMed Web of Science ®Google Scholar
• LIEBSCHER T, SCHNELL L, SCHNELL D et al.: Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann. Neurol. (2005) 58(5):706-719.
   PubMed Web of Science ®Google Scholar
• MERKLER D, METZ GA, RAINETEAU O, DIETZ V SCHWAB ME, FOUAD K: Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J. Neurosci. (2001) 21(10):3665-3673.
   PubMed Web of Science ®Google Scholar
• GRANDPRE T, LI S, STRITTMATTER SM: Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature (2002) 417(6888):547-551.
   PubMed Web of Science ®Google Scholar
• FOUAD K, KLUSMAN I, SCHWAB ME: Regenerating corticospinal fibers in the Marmoset (Callitrix jacchus) after spinal cord lesion and treatment with the anti-Nogo-A antibody IN-1. Eur. J. Neurosci. (2004) 20(9):2479-2482.
   PubMed Web of Science ®Google Scholar
• DERGHAM P, ELLEZAM B, ESSAGIAN C, AVEDISSIAN H, LUBELL WD, MCKERRACHER L: Rho signaling pathway targeted to promote spinal cord repair. J. Neurosci. (2002) 22(15):6570-6577.
   PubMed Web of Science ®Google Scholar
• FOUAD K, SCHNELL L, BUNGE MB et al.: Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J. Neurosci. (2005) 25(5):1169-1178.
   PubMed Web of Science ®Google Scholar
• BRADBURY EJ, MOON LD, POPAT RJ et al.: Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature (2002) 416(6881):636-640.
   PubMed Web of Science ®Google Scholar
• CAGGIANO AO, ZIMBER MP, GANGULY A, BLIGHT AR, GRUSKIN EA: Chondroitinase ABCI improves locomotion and bladder function following contusion injury of the rat spinal cord. J. Neurotrauma (2005) 22(2):226-239.
   PubMed Web of Science ®Google Scholar
• HALL ED, SPRINGER JE: Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx (2004) 1(1):80-100.
   PubMedGoogle Scholar
• LAMMERTSE DP: Update on pharmaceutical trials in acute spinal cord injury. J. Spinal Cord Med. (2004) 27(4):319-325.
   PubMedGoogle Scholar
• GEISLER FH, DORSEY FC, COLEMAN WP: Past and current clinical studies with GM-1 ganglioside in acute spinal cord injury. Ann. Emerg. Med. (1993) 22(6):1041-1047.
   PubMed Web of Science ®Google Scholar
• GEISLER FH, DORSEY FC, COLEMAN WP: GM-1 ganglioside in human spinal cord injury. J. Neurotrauma (1992) 9(Suppl. 2):S517-S530.
   Google Scholar
• GEISLER FH, DORSEY FC, COLEMAN WP: GM-1 ganglioside in human spinal cord injury. J. Neurotrauma (1992) 9(Suppl. 1):S407-S416.
   Google Scholar
• GEISLER FH, DORSEY FC, COLEMAN WP: Recovery of motor function after spinal-cord injury-a randomized, placebo-controlled trial with GM-1 ganglioside. N. Engl. J. Med. (1991) 324(26):1829-1838.
   PubMed Web of Science ®Google Scholar
• THOMPSON FJ, REIER PJ, UTHMAN B et al.: Neurophysiological assessment of the feasibility and safety of neural tissue transplantation in patients with syringomyelia. J. Neurotrauma (2001) 18(9):931-945.
   PubMed Web of Science ®Google Scholar
• WIRTH ED 3rd, REIER PJ, FESSLER RG et al.: Feasibility and safety of neural tissue transplantation in patients with syringomyelia. J. Neurotrauma (2001) 18(9):911-929.
   PubMed Web of Science ®Google Scholar
• DOBKIN BH, HAVTON LA: Basic advances and new avenues in therapy of spinal cord injury. Ann. Rev. Med. (2004) 55:255-282.
   Google Scholar
• AMADOR MJ, GUEST JD: An appraisal of ongoing experimental procedures in human spinal cord injury. J. Neurol. Phys. Ther. (2005) 29(2):70-86.
   PubMedGoogle Scholar